Immunogenic Cell Death Role in Urothelial Cancer Therapy

Immune escape mechanisms and immunotherapy of urothelial bladder cancer

Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities

Novel immunotherapy combinations for genitourinary cancers

Preliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118).

Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses

Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature

Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease

Current status of clinical trials assessing oncolytic virus therapy for urological cancers

Emerging role of immunotherapy in urothelial carcinoma-Advanced disease